Preclinical studies have demonstrated the efficacy of short-acting and the more recent long-acting GLP-1 receptor agonists to reduce alcohol self-administration, relapse-like behaviors, and binge drinking in rodent models (Egecioglu et al
The complete monitoring schedule Once you have baseline labs, you need a monitoring schedule
It can also help protect against atherosclerosis 31 , or hardening of the arteries, a major cause of heart disease
There are several Phase 3 trials evaluating GLP-1s for conditions, such as prediabetes, Alzheimer's disease, diabetic retinopathy and osteoarthritis of the knee (in patients with obesity)
Oral Semaglutide Pills for Weight Management: What to Know Date February 6, 2026 Credits Date February 6, 2026 Credits Medical providers featured in this article In Brief One GLP-1 receptor agonist drug is now available as a daily pill for weight management
Liz graduated from Pepperdine University with a degree in Biology in 1994